Yale Cardiovascular Research Group
14
3
6
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen
Role: collaborator
Serranator POINT FORCE Registry
Role: collaborator
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
Role: collaborator
The CONFORMAL Early Feasibility Study
Role: collaborator
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Role: collaborator
Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA
Role: collaborator
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR
Role: collaborator
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
Role: collaborator
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Role: collaborator
Encore PFO Closure Device - The PerFOrm Trial
Role: collaborator
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Role: collaborator
Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System
Role: collaborator
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
Role: collaborator
Shockwave Coronary Lithoplasty Study
Role: collaborator
All 14 trials loaded